Obstructive sleep apnea (OSA) is a prevalent sleep-related breathing disorder that is closely associated with cognitive impairment. However, the efficacy of conventional interventions remains limited, and exploring its neural mechanisms and adjunctive therapeutic strategies has become a research hotspot. This paper provides a narrative review of the research progress in neuroimaging mechanisms and intervention strategies for OSA-related cognitive impairment. Regarding neural mechanisms, this article focuses on two core mechanisms: dysfunction of the glymphatic system and unstable alterations in dynamic brain functional networks. Multimodal neuroimaging evidence demonstrates that patients with OSA exhibit distinct glymphatic system impairment and compromised dynamic reorganization ability of brain functional networks, characterized by "excessive persistence" and "abnormal transitions" of functional connectivity states. Pivotal mediation analyses have revealed for the first time the causal pathway of "glymphatic dysfunction → decreased brain network efficiency → cognitive impairment." In terms of intervention strategies, this article points out that continuous positive airway pressure (CPAP) has limited efficacy in improving cognitive function, accompanied by poor patient adherence. Non-invasive neuromodulation techniques represented by repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) show potential as adjunctive interventions due to their direct regulation of cortical excitability and neuroplasticity. Current research is limited by predominant cross-sectional designs, lack of standardized imaging biomarkers, and small sample sizes in intervention studies. Future research should focus on developing predictive models based on multimodal radiomics and artificial intelligence, exploring physical interventions targeting the glymphatic system, and conducting long-term randomized controlled trials enriched with biomarkers. This review aims to provide theoretical evidence and novel insights for the early identification and precise intervention of OSA-related cognitive impairment.
Hepatitis B virus (HBV) remains a major contributor to chronic liver disease worldwide and represents a significant global health challenge. The HBx protein plays an important role in HBV replication and viral pathogenesis and is therefore considered a promising therapeutic target. In the present study, an in silico molecular docking approach was employed to identify potential HBx inhibitors from a selected group of fourteen compounds. The three-dimensional structure of the HBx protein was predicted using the I-TASSER server, and the selected compounds were subjected to molecular docking using PyRx and AutoDock Vina. The docking results revealed that several compounds exhibited favorable predicted binding affinities toward HBx, with SC75741 showing the most favorable docking score (−9.8 kcal/mol), followed by Rutin (−9.1 kcal/mol), Cynarin (−8.6 kcal/mol), and Ledipasvir (−8.4 kcal/mol). Notably, Cynarin, which is not currently an approved anti-HBV drug, demonstrated a favorable docking score and interactions with several important HBx residues, highlighting its potential as a candidate lead compound for further investigation. Overall, the findings suggest that the identified compounds, particularly SC75741, Rutin, Cynarin, and Ledipasvir, may serve as potential candidates for HBx-targeted anti-HBV drug discovery.
Polycyclic aromatic hydrocarbons (PAHs), major atmospheric pollutants, have been associated with allergic respiratory disease, but the molecular links between individual PAHs and allergic rhinitis (AR) remain incompletely characterized. This in silico study explored predicted associations of three high-molecular-weight PAHs—benzo[a]pyrene (BaP), benzo[a]anthracene (BaA), and dibenz[a,h]anthracene (DBA)—with AR-related molecular networks. We integrated ADMET prediction (ADMETlab 2.0), multi-source target identification, network topology analysis (STRING and Cytoscape), functional enrichment (DAVID), and molecular docking (AutoDock Vina). ADMET analysis generated multiple toxicological alerts for all three compounds. Network analysis identified 191, 138, and 159 overlapping targets for the BaP-AR, BaA-AR, and DBA-AR datasets, respectively. BaP-associated targets were preferentially enriched in chemotaxis and chemokine signaling, whereas BaA- and DBA-associated targets were more strongly enriched in xenobiotic and cytochrome P450-related metabolic pathways. Molecular docking yielded energetically favorable predicted poses between BaP and chemokine-related hub proteins (CCL2, CCL5, CXCL8, CXCL12, and CXCR4) and between BaA/DBA and metabolic hub proteins, including ABCB1, CYP1A2, and CYP3A4. Taken together, these analyses generate a hypothesis that BaP may be preferentially associated with chemokine-related inflammatory networks, whereas BaA and DBA may be associated with metabolic-enzyme networks that could influence endogenous inflammatory mediator metabolism or drug disposition. Given its computational scope, this study yields in silico-generated hypotheses and candidate targets warranting experimental validation.
To explore the clinical value and potential risk of Qiliqiangxin Capsule, we designed a systematic review and meta-analysis on randomized controlled trials (RCTs), targeting patients diagnosed with both chronic heart failure and coronary artery disease. Our search included eight commonly used databases, focusing on studies that assessed the effectiveness of Qiliqiangxin Capsule and guideline-directed medical therapy for patients whose condition was chronic heart failure complicated by coronary artery disease. We conducted the meta-analysis employing the meta and metafor packages running under R 4.5.3, whereas the risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool. After systematic screening procedure, we included 17 studies, involving 2000 eligible patients. The results showed that Qiliqiangxin Capsule combination treatment reduced the occurrences of the primary outcome [RR=0.38,95%CI (0.23,0.63)], left ventricular ejection fraction (LVEF) [MD=5.39,95%CI (4.62,6.16)], left ventricular end-diastolic diameter (LVEDD) [MD=-4.86,95% CI(-6.20,-3.51)], N-terminal B-type natriuretic peptide precursor (NT-proBNP) levels [SMD = -0.82, 95% CI (-0.97, -0.67)], the 6-minute walk test distance (6MWD) [MD=39.05,95%CI(19.90,58.20)], and the clinical efficacy [RR = 1.20, 95% CI (1.14, 1.25)] were also significantly improved. As for the safety evaluation, the incidence of adverse events was not found to differ meaningfully [RR = 0.95, 95% CI (0.60, 1.50) ]. The combination of Qiliqiangxin Capsule and guideline-directed medical therapy can safely and effectively improve the heart failure rehospitalization and all-cause mortality in patients with chronic heart failure complicated by coronary artery disease, improve cardiac performance, increase physical capacity. However, further large sample trials are required to confirm the results.
To investigate the correlations between air pollutants and hematological parameters, and to develop a risk prediction model for understanding the health impacts of air pollution, grounded in the traditional Chinese concept of “the unity of heaven and man.”Data collected from 2019 to 2021 in the peripheral areas of Beijing were used. Six air pollutants (PM2.5, PM10, CO, SO2, NO2, O3) and 13 hematological parameters (LYP, MONO, MONP, MP, EOSA, EOSP, BASO, BASOP, MCH, MCHC, SD, PDW, PCT) were analyzed. Analytical methods included Pearson correlation, two-tailed tests, three-dimensional clustering, nonmetric multidimensional scaling, variance partition analysis, redundancy analysis, and multi-group and two-group difference analysis. Automated machine learning (AutoML) was used to predict the trends of air pollutant impacts on health indicators. Long-term exposure to air pollutants was positively correlated with MP, BASO, LYP, and EOSP, and negatively correlated with MCH and PCT. Age emerged as a significant factor influencing health, whereas sex did not modify the effect of air pollution on health indicators. This study provides new evidence on air pollution induced health damage and offers novel insights into the underlying mechanisms of how air pollutants affect human health.
CD8+ T cells are the core effector cells in anti-tumor immunity, but under continuous tumor antigen stimulation and inhibitory microenvironment, they gradually enter a state of dysfunction, showing reduced effector secretion, decreased proliferation, persistent expression of inhibitory receptors, and abnormal metabolic adaptation, which are driven by a unified transcriptional, epigenetic, metabolic, and microenvironmental exhaustion program. T cell exhaustion is a major reason why immune checkpoint blockade (ICB) therapy has limited effectiveness and also a key target for combination treatment strategies. In recent years, single-cell sequencing, spatial transcriptomics, and functional immunology studies have shown that exhausted T cells are not a single state-they include heterogeneous subgroups such as progenitor exhausted T cells (Tpex), intermediate exhausted T cells, and terminal exhausted T cells. Blocking PD-1/PD-L1 and CTLA-4 can partly restore T cell function, but primary and secondary resistance are still common. This article reviews the unified mechanisms of CD8+ T cell exhaustion and, organized around the axis of 'mechanism-heterogeneity-ICB response-combination strategies', explores potential strategies for immune checkpoint blockade related to CD8+ T cell exhaustion, and also discusses biomarkers and future research directions.